Author:
Heidrich Heinz,Breddin Hans,Rudofsky Gottfried,Scheffler Peter
Subject
Cardiology and Cardiovascular Medicine
Reference92 articles.
1. Bergström S, Ryhage R, Samuelsson B, et al (1963) Prostaglandins and related factors. The structure of prostaglandin E1, F1α and F1β. J Biol Chem 238:3555–3564.
2. Gruss JD, Vargas-Montano H, Bartels D, Simmenroth HW, Sakurai T, Schäfer G, Fietze-Fischer B (1984) Use of prostaglandins in arterial occlusive diseases. Inter Angio 3 (suppl):7–17.
3. Gryglewski RJ (1984) Prostacyclin. Pharmacology and clinical trials. Inter Angio 3(suppl):89–97.
4. Moncada S, Gryglewski RJ, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663–665.
5. Simmet Th, Peskar BA (1988) Prostaglandin E1 and arterial occlusive disease: Pharmacological considerations. Eur J Clin Invest 18:549–554.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献